About Zinc finger protein 736
Zinc finger protein 736 (ZNF736) is a protein
from Homo sapiens identified by UniProt accession
B4DX44, 427 residues long.
MolForge cross-references it against 0 known binders and
37 disease associations.
Target properties
| Protein name | Zinc finger protein 736 |
| UniProt accession | B4DX44 |
| Gene | ZNF736 |
| Organism | Homo sapiens |
| Length | 427 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (37)
Diseases linked to this target (Open Targets).
- PHF-tau measurement · score 0.31
- adolescent idiopathic scoliosis · score 0.31
- neurodegenerative disease · score 0.16
- eosinophil percentage of leukocytes · score 0.14
- Cystic Kidney Disease · score 0.06
- Down syndrome · score 0.06
- rheumatoid arthritis · score 0.05
- X-linked severe congenital neutropenia · score 0.04
- Blackfan-Diamond anemia · score 0.04
- neutropenia, severe congenital, 2, autosomal dominant · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-B4DX44-F1 | alphafold | PREDICTED | 72.37 | — |
Amino-acid sequence (427 residues)
MGVLTFRDVA VEFSPEEWEC LDSAQQRLYR DVMLENYGNL VSLGLAIFKP DLMTCLEQRK EPWKVKRQEA VAKHPAGSFH FTAEILPDHD IKDSFQKVIL RKYGSCDLNN LHLKKDYQSV GNCKGQKSSY NGLHQCLSAT HSKTCQCNKC GRGFQLCSIF TEHKDIFSRE KCHKCEECGK DCRLFSDFTR HKKIHTVERC YKCEECGKAF KKFSNLTEHK RVHTGEKPYK CEGCGKTFTC SSTLVKHKRN HTGDRPYKCE ECGKAFKCFS DLTNHKRIHT GEKPYKCEEC NKAYRWFSDL AKHKIIHTGD KPYTCNECGK AFKWFSALSK HKRIHTGEKP YICEECGKAF TRSSTLFNHK RIHMEERPYK CEECSKTFKC FSDLTNHKRI HTGEKPYKCE ECGKASSWFS HLIRHKRIHT REKLHKC
Explore Zinc finger protein 736 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets